PRO-2000 exhibits SARS-CoV-2 antiviral activity by interfering with spike-heparin binding
Evelien Vanderlinden(Rega Institute for Medical Research), Dominique Schols(Rega Institute for Medical Research)
Cited by 3
Related Papers
Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4
|FEBS Letters|2002|448